Please assess the completion status of the following clinical trial:

Trial Title: Renal Effects of Two Iodinated Contrast Media in Patients at Risk Undergoing Computed Tomography

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: DIAGNOSTIC
- Time Perspective: None
- Masking: TRIPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with a combination of diabetes mellitus (type I or II) and renal impairment who are referred for a contrast-enhanced CT examination.~Exclusion Criteria:~* Concurrent administration of potentially nephroprotective or nephrotoxic drugs is not permitted.~* Patients undergoing dialysis or kidney transplantation will not be included.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Iodixanol 320-Arm 1 (Type: ACTIVE_COMPARATOR): Iodixanol 320 mg I/mL
- Iopamidol 300-Arm 2 (Type: ACTIVE_COMPARATOR): Iopamidol 300 mg I/mL

Based on this trial design, predict the completion outcome and termination type (if applicable).